M. Gheorghiade
Cardiology and Cardiovascular Medicine · 1991–2016
A researcher in the Science corpus: 24 papers; trusts 5 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 223 citations into it; #668 of 906 by trust here, #62 by citations
- Nephrology — 20 citations into it
- Clinical Biochemistry — 8 citations into it
- Hematology — 8 citations into it
- Infectious Diseases — 6 citations into it
Whom M. Gheorghiade trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Fonarow
- J. Sackner-Bernstein
- F. Tenover
- C. Yancy
- J. Cleland
- M. Kowalski
- Douglas S. Lee
- Keith D. Aaronson
- T. Horwich
- J. Januzzi
Who trusts M. Gheorghiade overall
Papers from M. Gheorghiade's perspective
Ordered by how strongly the researchers M. Gheorghiade trusts endorse each paper. Same corpus, a different order for every researcher.
- Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. (Journal of the American Medical Association (JAMA))
- Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. (Journal of the American College of Cardiology)
- Acute Heart Failure Syndromes: Current State and Framework for Future Research (Circulation)
- Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. (Journal of the American College of Cardiology)
- Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (Journal of the American Medical Association (JAMA))
- Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. (Journal of the American College of Cardiology)
- In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry… (Journal of the American College of Cardiology)
- The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. (American Journal of Cardiology)
- [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology)
- State of the art: Using natriuretic peptide levels in clinical practice (European Journal of Heart Failure)
Their papers
- Mitochondrial function as a therapeutic target in heart failure (2016) — 649 citations
- The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (2014) — 1,968 citations
- Phenomapping for Novel Classification of Heart Failure with Preserved Ejection Fraction (2014) — 919 citations
- Rehospitalization for heart failure: problems and perspectives. (2013) — 720 citations
- Third universal definition of myocardial infarction (2013) — 3,166 citations
- Third universal definition of myocardial infarction. (2012) — 1,034 citations
- Third universal definition of myocardial infarction. (2012) — 953 citations
- Third universal definition of myocardial infarction. (2012) — 1,048 citations
- Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010) — 714 citations
- Acute heart failure syndromes (2009) — 643 citations
- Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2008) — 615 citations
- Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. (2007) — 1,159 citations
- Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. (2007) — 1,662 citations
- Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (2007) — 858 citations
- Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. (2006) — 1,194 citations
- HFSA 2006 comprehensive heart failure practice guideline (2006) — 833 citations
- Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. (2006) — 922 citations
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial (2006) — 621 citations
- Heart failure with preserved ejection fraction. (2006) — 901 citations
- Acute Heart Failure Syndromes: Current State and Framework for Future Research (2005) — 773 citations